Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
0 hedge funds and large institutions have $0 invested in Apollo Endosurgery, Inc. in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 89 closing their positions.
91.69% less ownership
Funds ownership: 91.69% → 0% (-92%)
100% less funds holding
Funds holding: 89 → 0 (-89)
100% less funds holding in top 10
Funds holding in top 10: 9 → 0 (-9)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $432M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 89
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
CPMG Inc
Dallas,
Texas
|
-$61.3M |
| 2 |
Nantahala Capital Management
New Canaan,
Connecticut
|
-$45.4M |
| 3 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$35.8M |
| 4 |
Citigroup
New York
|
-$19.8M |
| 5 |
Millennium Management
New York
|
-$18.4M |
APEN Hedge Fund Activity: Q2 2023 in Review
0 of the 6,387 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2023, worth a combined $0 — down 100% from $442M a quarter earlier.
Sellers outnumbered buyers: 89 funds closed out of APEN and 0 opened new positions — a net loss of 89 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was CPMG Inc, exiting entirely with an estimated $61.3M sold.
- 0 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2023, down from 89 in Q1 2023.
- Funds reported $0 of Apollo Endosurgery, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Apollo Endosurgery, Inc. positions in Q2 2023 and 89 closed out, a net change of -89 holders.
- The largest Apollo Endosurgery, Inc. seller in Q2 2023 was CPMG Inc, an estimated $61.3M sold.
Based on aggregated 13F filings for Q2 2023.